{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:03:47Z","timestamp":1766268227073,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.anndiagpath.2022.152101","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T12:09:35Z","timestamp":1672402175000},"page":"152101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal"],"prefix":"10.1016","volume":"63","author":[{"given":"Cynthia M.","family":"Magro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Kalomeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.anndiagpath.2022.152101_bb0005","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","article-title":"Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma","volume":"52","author":"Isaacson","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2022.152101_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/asheducation-2001.1.241","article-title":"MALT lymphomas","author":"Cavalli","year":"2001","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.anndiagpath.2022.152101_bb0015","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199608000-00010","article-title":"Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients","volume":"20","author":"Bailey","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2022.152101_bb0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152101_bb0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases","volume":"147","author":"Servitje","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2022.152101_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.anndiagpath.2018.02.006","article-title":"Small cell lymphocytic variant of marginal zone lymphoma: a distinct form of marginal zone lymphoma derived from na\u00efve B cells as a cutaneous counterpart to the na\u00efve marginal zone lymphoma of splenic origin","volume":"34","author":"Magro","year":"2018","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152101_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000478-199901000-00010","article-title":"Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features","volume":"23","author":"Baldassano","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.anndiagpath.2022.152101_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.2006.00506.x","article-title":"Pediatric primary cutaneous marginal zone lymphoma: in association with chronic antihistamine use","volume":"33","author":"Sroa","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DAD.0b013e318267495f","article-title":"Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature","volume":"35","author":"Magro","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/1042819021000055129","article-title":"Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma","volume":"44","author":"Martinez-Climent","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.anndiagpath.2022.152101_bb0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152101_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2559.1997.5450786.x","article-title":"Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma","volume":"30","author":"Peng","year":"1997","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.anndiagpath.2022.152101_bb0065","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anndiagpath.2022.152101_bb0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jcp.2010.076810","article-title":"Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas","volume":"63","author":"Chuang","year":"2010","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152101_bb0075","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/10428190109099348","article-title":"CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour","volume":"42","author":"Wenzel","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152101_bb0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0560.2006.00653.x","article-title":"The expression of CD23 and CD40 in primary cutaneous B-cell lymphomas","volume":"34","author":"Magro","year":"2007","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152101_bb0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2141.1996.522522.x","article-title":"Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization","volume":"93","author":"Dierlamm","year":"1996","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152101_bb0090","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0046-8177(99)90098-9","article-title":"Trisomy 3 in gastric lymphomas of extranodal marginal zone B-cell (mucosa-associated lymphoid tissue) origin demonstrated by FISH in intact paraffin tissue sections","volume":"30","author":"Blanco","year":"1999","journal-title":"Hum Pathol"},{"issue":"23","key":"10.1016\/j.anndiagpath.2022.152101_bb0095","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2169\/internalmedicine.48.2424","article-title":"Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18","volume":"48","author":"Sunohara","year":"2009","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.anndiagpath.2022.152101_bb0100","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the splenic B-cell lymphoma group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/1042819021000055129","article-title":"Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma","volume":"44","author":"Martinez-Climent","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"10.1016\/j.anndiagpath.2022.152101_bb0110","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1080\/10428194.2021.1966783","article-title":"Molecular- and cytogenetic characterization of the IGH associated t(1;14) in a nodal marginal zone B-cell lymphoma case","volume":"62","author":"Aky\u00fcz","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152101_bb0115","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/gcc.1150","article-title":"Molecular-cytogenetic comparison of mucosa- associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract","volume":"31","author":"Barth","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152101_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00239-3","article-title":"Analysis of the P53, RB\/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: an interphase fluorescence in situ hybridization study","volume":"120","author":"Dierlamm","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10428194.2019.1675877","article-title":"The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies","volume":"61","author":"Filip","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3960\/jslrt.55.175","article-title":"Nodal marginal zone large B-cell lymphoma with burkitt translocation and complex chromosomal changes associated with overexpression of BCL2, MYC, and BCL6","volume":"55","author":"Jelic","year":"2015","journal-title":"J Clin Exp Hematop"},{"issue":"9","key":"10.1016\/j.anndiagpath.2022.152101_bb0135","first-page":"5634","article-title":"C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas","volume":"7","author":"Huang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"24","key":"10.1016\/j.anndiagpath.2022.152101_bb0140","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3960\/jslrt.56.145","article-title":"TET2 mutation in diffuse large B-cell lymphoma","volume":"56","author":"Kubuki","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.anndiagpath.2022.152101_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109105","article-title":"A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma","volume":"243","author":"Wang","year":"2022","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152101_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/DAD.0b013e31804795a6","article-title":"Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH\/BCL2 and the t(14;18)(q32;q21) IGH\/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?","volume":"29","author":"Palmedo","year":"2007","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152101_bb0160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/DAD.0000000000002053","article-title":"Histological transformation and clonal relationship of subcutaneous marginal zone B-cell lymphoma and diffuse large B-cell lymphoma","volume":"44","author":"Abbott","year":"2022","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152101_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2008.04.012","article-title":"Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome in primary cutaneous marginal zone lymphoma","volume":"59","author":"Gerami","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422002039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422002039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:35:44Z","timestamp":1761078944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":33,"alternative-id":["S1092913422002039"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152101","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152101"}}